Pantoprazole Sodium and Domperidone Tablets | PANFAB-D

By akash midha, 12 September, 2025

 

Introduction
PANFAB-D is a trusted formulation combining Pantoprazole Sodium and Domperidone, designed to provide complete relief from acid-related gastrointestinal disorders. Pantoprazole, a proton pump inhibitor (PPI), works by suppressing stomach acid production, while Domperidone, a prokinetic agent, improves gastric motility and prevents nausea or bloating. Manufactured under strict WHO-GMP guidelines, PANFAB-D ensures effectiveness, safety, and superior patient outcomes.

Composition & Mechanism of Action

  • Pantoprazole Sodium: Reduces excessive stomach acid by inhibiting proton pumps in gastric parietal cells. This provides long-lasting acid suppression and promotes healing of ulcers.

     

  • Domperidone: Enhances gastric emptying, increases lower esophageal sphincter tone, and controls nausea, vomiting, and bloating.

     

Together, this dual-action formula not only manages acidity but also relieves reflux-related discomfort, making PANFAB-D highly effective in patients with both acid reflux and motility disorders.

Therapeutic Indications

PANFAB-D is indicated in a wide range of gastro-intestinal conditions, such as:

  • Gastroesophageal Reflux Disease (GERD): Effective in controlling heartburn, regurgitation, and chronic reflux.

     

  • Acid Peptic Disorders: Promotes healing of gastric and duodenal ulcers.

     

  • Dyspepsia & Bloating: Relieves fullness and discomfort after meals.

     

  • Esophagitis: Provides symptomatic relief in reflux-induced esophagitis.

     

  • Nausea & Vomiting: Manages reflux-related nausea and gastric stasis symptoms.

     

  • Functional Dyspepsia: Useful in patients with delayed gastric emptying.

     

    Shop Primary Image

Dosage & Administration

  • Recommended Dosage: One tablet, once or twice daily, as directed by a physician.

     

  • Timing: Best taken before meals to ensure maximum effectiveness.

     

  • Duration: Therapy length depends on the condition (4–8 weeks for GERD/ulcers, longer for chronic reflux disorders).

     

  • Special Instructions: Patients with liver or kidney impairment may require dose adjustments.

     

  • Missed Dose: If missed, take it as soon as possible but avoid doubling the next dose.

     

Benefits of PANFAB-D

  • Dual Action Formula: Combines acid suppression with enhanced gastric motility.

     

  • Fast & Long-lasting Relief: Effective against heartburn, nausea, and bloating.

     

  • Prevents Ulcer Recurrence: Promotes healing and reduces chances of relapse.

     

  • Improves Digestion: Helps patients with functional dyspepsia and delayed emptying.

     

  • Convenient Dosing: Once/twice daily dosage improves patient compliance.

     

  • Assured Quality: Manufactured under WHO-GMP standards for safety and efficacy.

     

Safety & Precautions

Although PANFAB-D is generally well tolerated, mild side effects may occur, such as headache, dry mouth, nausea, dizziness, or diarrhea.

  • Contraindications: Not suitable for patients with GI bleeding, perforation, or hypersensitivity to PPIs or Domperidone.

     

  • Drug Interactions: May interact with antifungal drugs, antivirals, and blood thinners.

     

  • Pregnancy & Lactation: Should only be used if recommended by a physician.

     

  • Storage: Keep in a cool, dry place away from moisture and direct sunlight.

     

Conclusion

PANFAB-D (Pantoprazole Sodium and Domperidone Tablets) is a highly effective treatment for acid-related gastrointestinal conditions. By combining the acid-suppressing effect of Pantoprazole with the prokinetic benefits of Domperidone, it provides comprehensive relief from GERD, ulcers, nausea, and bloating. With superior quality, safety assurance, and affordability, PANFAB-D is a reliable choice for healthcare professionals and patients alike.